Recruitment

Recruitment Status
Completed
Estimated Enrollment
10

Inclusion Criteria

Age ≥3 years and ≤21 years
Is being evaluated for surgical resection of the mass
Subject and/or guardian is able to provide written informed consent prior to study registration
...
Age ≥3 years and ≤21 years
Is being evaluated for surgical resection of the mass
Subject and/or guardian is able to provide written informed consent prior to study registration
Newly diagnosed, untreated mass in posterior fossa, either benign or malignant
Able to perform clinical language testing in English

Exclusion Criteria

Pregnant or nursing female
Does not speak English as a primary language (as determined by the P.I. or treating physician after discussion with a potential subject and his/her family)
Any contraindication to MRI (e.g., pacemaker, aneurysm clip, tissue expander).
...
Pregnant or nursing female
Does not speak English as a primary language (as determined by the P.I. or treating physician after discussion with a potential subject and his/her family)
Any contraindication to MRI (e.g., pacemaker, aneurysm clip, tissue expander).
Claustrophobia
Preexisting language or developmental disorder that would limit ability to cooperate with testing (as determined by the P.I. or treating physician after interviewing potential subject and his/her family; for example, a child may be excluded if he/she has confirmed or suspected autism spectrum disorder, dysarthria, dyslexia, lisp, hypotonia, or other age inappropriate speech development)

Summary

Conditions
Brain Mass
Type
Observational
Design
  • Observational Model: Cohort
  • Time Perspective: Prospective

Participation Requirements

Age
Between 3 years and 21 years
Gender
Both males and females

Inclusion Criteria

Age ≥3 years and ≤21 years
Is being evaluated for surgical resection of the mass
Subject and/or guardian is able to provide written informed consent prior to study registration
...
Age ≥3 years and ≤21 years
Is being evaluated for surgical resection of the mass
Subject and/or guardian is able to provide written informed consent prior to study registration
Newly diagnosed, untreated mass in posterior fossa, either benign or malignant
Able to perform clinical language testing in English

Exclusion Criteria

Pregnant or nursing female
Does not speak English as a primary language (as determined by the P.I. or treating physician after discussion with a potential subject and his/her family)
Any contraindication to MRI (e.g., pacemaker, aneurysm clip, tissue expander).
...
Pregnant or nursing female
Does not speak English as a primary language (as determined by the P.I. or treating physician after discussion with a potential subject and his/her family)
Any contraindication to MRI (e.g., pacemaker, aneurysm clip, tissue expander).
Claustrophobia
Preexisting language or developmental disorder that would limit ability to cooperate with testing (as determined by the P.I. or treating physician after interviewing potential subject and his/her family; for example, a child may be excluded if he/she has confirmed or suspected autism spectrum disorder, dysarthria, dyslexia, lisp, hypotonia, or other age inappropriate speech development)

Tracking Information

NCT #
NCT01733173
Collaborators
Not Provided
Investigators
  • Principal Investigator: Robert J. Young, MD Memorial Sloan Kettering Cancer Center
  • Robert J. Young, MD Memorial Sloan Kettering Cancer Center